» Articles » PMID: 33534816

Heat-stability Study of Various Insulin Types in Tropical Temperature Conditions: New Insights Towards Improving Diabetes Care

Abstract

Strict storage recommendations for insulin are difficult to follow in hot tropical regions and even more challenging in conflict and humanitarian emergency settings, adding an extra burden to the management of people with diabetes. According to pharmacopeia unopened insulin vials must be stored in a refrigerator (2-8°C), while storage at ambient temperature (25-30°C) is usually permitted for the 4-week usage period during treatment. In the present work we address a critical question towards improving diabetes care in resource poor settings, namely whether insulin is stable and retains biological activity in tropical temperatures during a 4-week treatment period. To answer this question, temperature fluctuations were measured in Dagahaley refugee camp (Northern Kenya) using log tag recorders. Oscillating temperatures between 25 and 37°C were observed. Insulin heat stability was assessed under these specific temperatures which were precisely reproduced in the laboratory. Different commercialized formulations of insulin were quantified weekly by high performance liquid chromatography and the results showed perfect conformity to pharmacopeia guidelines, thus confirming stability over the assessment period (four weeks). Monitoring the 3D-structure of the tested insulin by circular dichroism confirmed that insulin monomer conformation did not undergo significant modifications. The measure of insulin efficiency on insulin receptor (IR) and Akt phosphorylation in hepatic cells indicated that insulin bioactivity of the samples stored at oscillating temperature during the usage period is identical to that of the samples maintained at 2-8°C. Taken together, these results indicate that insulin can be stored at such oscillating ambient temperatures for the usual four-week period of use. This enables the barrier of cold storage during use to be removed, thereby opening up the perspective for easier management of diabetes in humanitarian contexts and resource poor settings.

Citing Articles

Impact of insulin storage and syringe reuse on insulin sterility in diabetes mellitus patients in Mwanza Tanzania.

Kimaro E, John J, Damiano P, Konje E, Mori A, Kidenya B Sci Rep. 2025; 15(1):6232.

PMID: 39979407 PMC: 11842541. DOI: 10.1038/s41598-025-91029-5.


Burden of Disease in Refugee Patients with Diabetes on the Island of Lesvos-The Experience of a Frontline General Hospital.

Bountouvis N, Koumpa E, Skoutarioti N, Kladitis D, Exadaktylos A, Anitsakis C Int J Environ Res Public Health. 2024; 21(7).

PMID: 39063405 PMC: 11276869. DOI: 10.3390/ijerph21070828.


Global Warming and Endocrinology: The Hyderabad Declaration of the South Asian Federation of Endocrine Societies.

Bhattacharya S, Sahay R, Afsana F, Sheikh A, Widanage N, Maskey R Indian J Endocrinol Metab. 2024; 28(2):129-136.

PMID: 38911103 PMC: 11189284. DOI: 10.4103/ijem.ijem_473_23.


Living with and managing type 1 diabetes in humanitarian settings: A qualitative synthesis of lived experience and stakeholder tacit knowledge.

James O, Abbou-Abbas L, Vijayasingham L PLOS Glob Public Health. 2024; 4(6):e0003027.

PMID: 38905318 PMC: 11192347. DOI: 10.1371/journal.pgph.0003027.


Microfluidic Delivery of High Viscosity Liquids Using Piezoelectric Micropumps for Subcutaneous Drug Infusion Applications.

Surendran N, Durasiewicz C, Hoffmann T, Wille A, Bussmann A, Richter M IEEE Open J Eng Med Biol. 2024; 5:21-31.

PMID: 38487095 PMC: 10939327. DOI: 10.1109/OJEMB.2024.3355692.


References
1.
Veurink M, Stella C, Tabatabay C, Pournaras C, Gurny R . Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment. Eur J Pharm Biopharm. 2010; 78(2):271-7. DOI: 10.1016/j.ejpb.2010.12.018. View

2.
Sarmento B, Ribeiro A, Veiga F, Ferreira D . Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed Chromatogr. 2006; 20(9):898-903. DOI: 10.1002/bmc.616. View

3.
Oliva A, Suarez M, Hernandez J, Llabres M, Farina J . Evaluation of non-isothermal methods in stability studies of human insulin pharmaceutical preparations. J Pharm Biomed Anal. 2009; 49(4):916-22. DOI: 10.1016/j.jpba.2009.01.024. View

4.
Vinther T, Norrman M, Ribel U, Huus K, Schlein M, Steensgaard D . Insulin analog with additional disulfide bond has increased stability and preserved activity. Protein Sci. 2013; 22(3):296-305. PMC: 3595460. DOI: 10.1002/pro.2211. View

5.
Banerjee V, Kar R, Datta A, Parthasarathi K, Chatterjee S, Das K . Use of a small peptide fragment as an inhibitor of insulin fibrillation process: a study by high and low resolution spectroscopy. PLoS One. 2013; 8(8):e72318. PMC: 3756998. DOI: 10.1371/journal.pone.0072318. View